UCB : presents new data at 35th International Epilepsy Congr

UCB : presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla▼(fenfluramine) oral solution and broader epilepsies portfolio -Today at 01:04 am

was conducted to examine the efficacy of fenfluramine on GTCS reduction in various types of Developmental and Epileptic Encephalopathies or rare epilepsy conditions. Data from 13 studies , 4...

Related Keywords

Belgium , Lingfield , Surrey , United Kingdom , London , City Of , Brussels , Bruxelles Capitale , Dublin , Ireland , Nick Francis , Pina Garza , Mike Davis , Encephalopathies Dees , Orrin Devinsky , Helen Cross , Antje Witte , Laurent Schots , European Society Of Cardiology , Langone Health Comprehensive Epilepsy Center , European Respiratory Society , International Epilepsy Congress , Subgroup Data From The International , Corporate Communications , Twitter , Institute Of Child Health , Global Communications , Group Of Companies , Global Epilepsy , Rare Syndromes , Epileptic Encephalopathies , Professor Helen Cross , Childhood Epilepsy , Ormond Street Institute , Child Health , Young Epilepsy , Sudden Unexpected Death , Comprehensive Epilepsy Center , Early Seizure , Seizure Termination , European Summary , Product Characteristics , Safety Information , Euronext Brussels , Accessed August , Generalized Tonic Clonic Seizures , Rare Epilepsy Syndromes , Adult Patients , Dravet Syndrome Enrolled De Novo , Open Label Extension , Drop Seizure Frequency , Dose Capped Patients With Lennox Gastaut Syndrome , Comparative Analysis , Clinical Trial , Month Effectiveness , Patients With Epilepsy Stratified , Subgroup Data From , Seizure Termination Project , Expert Consensus Recommendations , Rapid Termination , Subjects With , Disorder Followed , Markets ,

© 2025 Vimarsana